Specific fetal malformations following intrauterine exposure to antiseizure medication
Open Access
- 21 April 2023
- journal article
- research article
- Published by Elsevier in Epilepsy & Behavior
- Vol. 142, 109219
Abstract
No abstract availableKeywords
Funding Information
- Epilepsy Society of Australia
- Royal Melbourne Hospital Neuroscience Foundation
- Royal Melbourne Hospital
- National Health and Medical Research Council
This publication has 13 references indexed in Scilit:
- Zonisamide safety in pregnancy: Data from the UK and Ireland epilepsy and pregnancy registerSeizure: European Journal of Epilepsy, 2021
- The Risk of Congenital Anomalies by Fertility Treatment ModalityObstetrical & Gynecological Survey, 2021
- Influence of periconception smoking behavior on birth defect riskAmerican Journal of Obstetrics and Gynecology, 2019
- Congenital heart defects in IVF/ICSI pregnancy: systematic review and meta‐analysisUltrasound in Obstetrics & Gynecology, 2018
- Birth defects and assisted reproductive technologiesSeminars in Fetal and Neonatal Medicine, 2014
- Associations between particular types of fetal malformation and antiepileptic drug exposurein uteroActa Neurologica Scandinavica, 2013
- The Australian Pregnancy Register of Anti-epileptic Drugs : 10 years of progressJournal of Clinical Neuroscience, 2010
- Valproic Acid Monotherapy in Pregnancy and Major Congenital MalformationsNew England Journal of Medicine, 2010
- The Australian antiepileptic drug in pregnancy register: Aspects of data collection and analysisJournal of Clinical Neuroscience, 2007
- Congenital Malformations Associated with Maternal Use of Valproic AcidCanadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, 1987